Environmental Toxicant Induced Epigenetic Transgenerational Inheritance of Prostate Pathology and Stromal-Epithelial Cell Epigenome and Transcriptome Alterations: Ancestral Origins of Prostate Disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 02 2019
Historique:
received: 06 07 2018
accepted: 09 01 2019
entrez: 20 2 2019
pubmed: 20 2 2019
medline: 12 9 2020
Statut: epublish

Résumé

Prostate diseases include prostate cancer, which is the second most common male neoplasia, and benign prostatic hyperplasia (BPH), which affects approximately 50% of men. The incidence of prostate disease is increasing, and some of this increase may be attributable to ancestral exposure to environmental toxicants and epigenetic transgenerational inheritance mechanisms. The goal of the current study was to determine the effects that exposure of gestating female rats to vinclozolin has on the epigenetic transgenerational inheritance of prostate disease, and to characterize by what molecular epigenetic mechanisms this has occurred. Gestating female rats (F0 generation) were exposed to vinclozolin during E8-E14 of gestation. F1 generation offspring were bred to produce the F2 generation, which were bred to produce the transgenerational F3 generation. The transgenerational F3 generation vinclozolin lineage males at 12 months of age had an increased incidence of prostate histopathology and abnormalities compared to the control lineage. Ventral prostate epithelial and stromal cells were isolated from F3 generation 20-day old rats, prior to the onset of pathology, and used to obtain DNA and RNA for analysis. Results indicate that there were transgenerational changes in gene expression, noncoding RNA expression, and DNA methylation in both cell types. Our results suggest that ancestral exposure to vinclozolin at a critical period of gestation induces the epigenetic transgenerational inheritance of prostate stromal and epithelial cell changes in both the epigenome and transcriptome that ultimately lead to prostate disease susceptibility and may serve as a source of the increased incidence of prostate pathology observed in recent years.

Identifiants

pubmed: 30778168
doi: 10.1038/s41598-019-38741-1
pii: 10.1038/s41598-019-38741-1
pmc: PMC6379561
doi:

Substances chimiques

Hazardous Substances 0
RNA, Untranslated 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2209

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM110767
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES012974
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD085506
Pays : United States

Références

Cell Signal. 2001 Oct;13(10):703-9
pubmed: 11602180
Arch Androl. 2006 Jul-Aug;52(4):275-81
pubmed: 16728343
Can J Urol. 2015 Oct;22 Suppl 1:1-6
pubmed: 26497338
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Differentiation. 2017 Jul - Aug;96:40-48
pubmed: 28779656
Int J Biol Sci. 2015 Jun 11;11(8):948-60
pubmed: 26157349
Reproduction. 2008 May;135(5):713-21
pubmed: 18304984
Prostate. 2013 Jun;73(9):941-51
pubmed: 23334998
Pathol Res Pract. 2014 Feb;210(2):74-8
pubmed: 24252309
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Reprod Toxicol. 2008 Jan;25(1):2-6
pubmed: 17949945
Arch Esp Urol. 2014 Jun;67(5):373-82
pubmed: 24914835
Br J Urol. 1997 Apr;79 Suppl 2:18-26
pubmed: 9126066
PLoS One. 2014 Jul 24;9(7):e102091
pubmed: 25057798
BMC Cancer. 2012 Jun 06;12:222
pubmed: 22673095
BMC Genomics. 2014 Aug 20;15:692
pubmed: 25142051
Mol Endocrinol. 2013 Oct;27(10):1617-31
pubmed: 23893956
Epigenetics Chromatin. 2018 Feb 27;11(1):8
pubmed: 29482626
Endocrinology. 2018 Feb 1;159(2):945-956
pubmed: 29194490
Mol Cell Endocrinol. 2014 Dec;398(1-2):4-12
pubmed: 25088466
Nucleic Acids Res. 2015 Jan;43(Database issue):D662-9
pubmed: 25352552
Endocr Rev. 1987 Aug;8(3):338-62
pubmed: 3308446
Epigenetics. 2018;13(8):875-895
pubmed: 30207508
Science. 2016 Jan 22;351(6271):397-400
pubmed: 26721680
Semin Reprod Med. 2006 Jul;24(3):168-77
pubmed: 16804815
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
PLoS One. 2018 Aug 29;13(8):e0202662
pubmed: 30157260
Nucleic Acids Res. 2014 Jan;42(Database issue):D199-205
pubmed: 24214961
Cell. 2014 Jul 17;158(2):277-287
pubmed: 25018105
Reprod Toxicol. 2017 Apr;69:60-67
pubmed: 28115265
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nat Protoc. 2013 Aug;8(8):1551-66
pubmed: 23868073
Biomed Res Int. 2014;2014:502093
pubmed: 25089270
J Gerontol A Biol Sci Med Sci. 2019 May 16;74(6):751-759
pubmed: 29762647
PLoS One. 2013;8(1):e55387
pubmed: 23359474
Endocrinology. 1998 Mar;139(3):1369-77
pubmed: 9492074
Am J Anat. 1972 May;134(1):107-25
pubmed: 5031972
Genome Biol. 2012 Oct 03;13(10):R91
pubmed: 23034163
Trends Endocrinol Metab. 2010 Apr;21(4):214-22
pubmed: 20074974
Birth Defects Res B Dev Reprod Toxicol. 2014 Dec;101(6):410-22
pubmed: 25477288
Prostate. 2015 Oct;75(14):1662-8
pubmed: 26184773
PLoS One. 2012;7(2):e31901
pubmed: 22389676
Toxicology. 2009 Aug 21;262(3):215-23
pubmed: 19549552
Prostate. 2007 Sep 1;67(12):1255-64
pubmed: 17596848
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Endocrinology. 2006 Dec;147(12):5515-23
pubmed: 16973726
Clin Cancer Res. 2014 Jan 1;20(1):100-9
pubmed: 24150235
Mol Cell Endocrinol. 2014 Dec;398(1-2):24-30
pubmed: 25224488
Prostate. 2008 Apr 1;68(5):517-29
pubmed: 18220299
Environ Epigenet. 2018 Apr 26;4(2):dvy010
pubmed: 29732173
Bioinformatics. 2014 Jan 15;30(2):284-6
pubmed: 24227674
PLoS One. 2013;8(3):e59922
pubmed: 23555832
J Cell Physiol. 1999 Jul;180(1):53-60
pubmed: 10362017
PLoS One. 2012;7(5):e36129
pubmed: 22570695
Dev Biol. 2003 Jan 15;253(2):165-74
pubmed: 12645922
Reprod Toxicol. 2013 Apr;36:104-16
pubmed: 23453003
Prostate. 2005 Aug 1;64(3):253-64
pubmed: 15717313
Environ Epigenet. 2019 May 27;5(2):dvz008
pubmed: 31186947
BMC Genomics. 2016 Jun 01;17:418
pubmed: 27245821
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Reprod Toxicol. 2012 Dec;34(4):708-19
pubmed: 22975477
J Steroid Biochem Mol Biol. 2011 Oct;127(1-2):83-95
pubmed: 21827855
PLoS One. 2012;7(9):e46249
pubmed: 23049995
Science. 2005 Jun 3;308(5727):1466-9
pubmed: 15933200
Reprod Biomed Online. 2008 Jan;16(1):23-5
pubmed: 18252044

Auteurs

Rachel Klukovich (R)

Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA.

Eric Nilsson (E)

Center for Reproductive Biology, School of Biological Sciences, Washington State University, Pullman, WA, 99164-4236, USA.

Ingrid Sadler-Riggleman (I)

Center for Reproductive Biology, School of Biological Sciences, Washington State University, Pullman, WA, 99164-4236, USA.

Daniel Beck (D)

Center for Reproductive Biology, School of Biological Sciences, Washington State University, Pullman, WA, 99164-4236, USA.

Yeming Xie (Y)

Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA.

Wei Yan (W)

Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA. wyan@med.unr.edu.

Michael K Skinner (MK)

Center for Reproductive Biology, School of Biological Sciences, Washington State University, Pullman, WA, 99164-4236, USA. skinner@wsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH